Literature DB >> 33622862

Regenerative Therapy Using Umbilical Cord Serum.

Nagarajan Maharajan1,2, Gwang-Won Cho1,2, Ji Hyun Choi3, Chul Ho Jang4.   

Abstract

Regenerative medicine is a branch of medicine that incorporates tissue-engineering, biomaterials, and cell therapy approaches to replace or repair damaged cells and tissues. Umbilical cord serum (UCS) is an important liquid component of cord blood, which has a reliable source of innumerable growth factors and biologically active molecules. Usually, serum can be prepared from different sources of blood. In therapeutic application, cord serum can be prepared and used in the form of eye drops for the treatment of severe dry eye diseases, ocular burns, glaucoma, persistent corneal epithelial defects and neurotrophic keratitis. In addition, cord serum combined with synthetic bio scaffold materials is used to regenerate different types of tissues including tympanic membrane regeneration, bone regeneration and nerve regeneration. Absence of animal origin viruses and bacteria, lack of xenoproteins and cost-effective features make cord serum a feasible choice as replacement of fetal bovine serum in cell culture techniques. Thus, this review emphasizes the role of cord serum in regenerative therapy and clinical uses. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Umbilical cord serum; cytokines; growth factors; regeneration; review

Year:  2021        PMID: 33622862      PMCID: PMC8045055          DOI: 10.21873/invivo.12310

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  61 in total

1.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects.

Authors:  R B Vajpayee; N Mukerji; R Tandon; N Sharma; R M Pandey; N R Biswas; N Malhotra; S A Melki
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Tracheal regeneration using polycaprolactone/collagen-nanofiber coated with umbilical cord serum after partial resection.

Authors:  Yoon Seok Jang; Chul Ho Jang; Yong Beom Cho; Minseong Kim; Geun Hyung Kim
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-10-25       Impact factor: 1.675

Review 3.  Tissue engineering of the tympanic membrane.

Authors:  Bing Mei Teh; Robert J Marano; Yi Shen; Peter L Friedland; Rodney J Dilley; Marcus D Atlas
Journal:  Tissue Eng Part B Rev       Date:  2012-11-29       Impact factor: 6.389

Review 4.  Growth factors to stimulate bone formation.

Authors:  D J Baylink; R D Finkelman; S Mohan
Journal:  J Bone Miner Res       Date:  1993-12       Impact factor: 6.741

Review 5.  Interleukin-8, a chemotactic and inflammatory cytokine.

Authors:  M Baggiolini; I Clark-Lewis
Journal:  FEBS Lett       Date:  1992-07-27       Impact factor: 4.124

6.  Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.

Authors:  Kyung-Chul Yoon; In-Cheon You; Seong-Kyu Im; Tae-Sun Jeong; Yeoung-Geol Park; Jin Choi
Journal:  Ophthalmology       Date:  2007-03-26       Impact factor: 12.079

7.  Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia.

Authors:  C Chiesa; G Pellegrini; A Panero; T De Luca; M Assumma; F Signore; L Pacifico
Journal:  Eur J Clin Invest       Date:  2003-04       Impact factor: 4.686

Review 8.  Vascular endothelial growth factor and angiogenesis.

Authors:  Ann Hoeben; Bart Landuyt; Martin S Highley; Hans Wildiers; Allan T Van Oosterom; Ernst A De Bruijn
Journal:  Pharmacol Rev       Date:  2004-12       Impact factor: 25.468

9.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

Review 10.  Application of Novel Drugs for Corneal Cell Regeneration.

Authors:  Sang Beom Han; Yu-Chi Liu; Karim Mohamed-Noriega; Jodhbir S Mehta
Journal:  J Ophthalmol       Date:  2018-05-02       Impact factor: 1.909

View more
  1 in total

1.  Examination of Trace Metals and Their Potential Transplacental Transfer in Pregnancy.

Authors:  Jovana Jagodić; Slađan Pavlović; Slavica Borković-Mitić; Milan Perović; Željko Miković; Slađana Đurđić; Dragan Manojlović; Aleksandar Stojsavljević
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.